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Stereotactic interventions form an increasingly significant portion of the minimally
invasive approaches for surgical management of epilepsy.1,2 This manuscript will review
the application of three recent stereotactic techniques in the modern epilepsy surgery
armamentarium, namely stereotactic electroencephalography (SEEG), responsive neural
stimulation (RNS) and laser interstitial thermal therapy (LITT). While these interventions
are a contemporary advancement, they are intellectually indebted to some of the most
major developments and pioneers in the history of neurosurgery. Sir Victor Horsley,
the father of modern neurosurgery, and Robert Clarke developed the first stereotactic
frame in 1908, but use of the stereotactic coordinate space did not find wide use until it
could be paired with intracranial imaging. Acquisition of pneumoencephalograms and/
or arterial angiography (developed by Dandy and Moniz, respectively) with a stereotactic
reference frame enabled Spiegel and Wycis to precisely localize brain structures.3 The
ability to attain sub-millimeter accuracy followed the advent of computed tomography
(CT) and magnetic resonance imaging (MRI). These advancements were applied to
epilepsy first by Bancaud and Talairach with their development of SEEG.4 While LITT
and RNS represent more recent advancements, they are indebted to the work of Lars
Leksell and Alim Benabid for their pioneering work in stereotactic ablative therapy and
deep brain stimulation (DBS), respectively.

STEREOTACTIC EEG
As with all surgical interventions for epilepsy, the decision to pursue SEEG recording
must serve to test an anatomo-electro-clinical (AEC) hypothesis.5 At Thomas Jefferson,
a multi-disciplinary surgical epilepsy conference, including clinicians from the departments of Neurology, Neurosurgery, Neuropsychology, and Neuroradiology, evaluates
all potential surgical candidates. Invasive intracranial monitoring is indicated in cases in
which phase I monitoring with surface EEG fails to lateralize and/or localize a presumed
focal epileptic onset zone, particularly in the context of discordant data derived from
EEG, MRI, neuropsychologic testing, and functional imaging such as positron emission
tomography (PET). It cannot be over-emphasized that decision-making with regard to
intracranial implant strategy must serve to test the AEC hypothesis, and so-called “fishing
expeditions” should be avoided at all costs.
Historically, intracranial monitoring has developed along two major pathways, strip/
grid electrodes placed over the cortical surface or depth electrodes placed into brain
tissue itself. Following its introduction by Talairach and Bancaud in the 1950’s, SEEG has
seen widespread use in European epilepsy centers. However, initial safety concerns and
the complexity associated with surgical planning prior to modern multimodal imaging
limited its use in North America, resulting in a general preference for subdural strip
and grid electrodes.6,7 With substantial evidence regarding safety and clinical utility,
there has been a significant resurgence of interest in SEEG in North America in the last
decade. Stereotactic EEG offers several distinct advantages relative to subdural strip/grid
recordings. First, SEEG offers the ability to record from deep-seated structures that are
poorly interrogated by scalp or strip/grid electrodes, such as subdivisions of the mesial
temporal structures, cingulate gyrus, insula/operculum, and the depths of sulci. Second,
individually tailored implants may be designed to interrogate network structures up- and
down-stream from the presumed symptomatogenic zone.8,9 Furthermore, our group
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has found distinct advantages with SEEG
in terms of safety and patient comfort for
large bihemispheric implantations and in
patients with prior history of craniotomy.
Finally, SEEG allows for the generation of
a four dimensional picture of epileptogenic zone and spread patterns, which is
not reliably achieved with cortical surface
recording techniques. As such, our
center is actively pursuing SEEG-based
white-matter recording guided by functional imaging to further define cerebral
networks and spread patterns in epilepsy.
At Jefferson, SEEG implantation planning
is performed with the use of co-registered
multimodal imaging. Imaging is obtained
at least two weeks prior to surgery in
order to facilitate the complex nature of
surgical planning. High-resolution gadolinium-enhanced T1-weighted images
with sub-millimeter isometric voxels (to
minimize spatial warping during multiplanar reconstruction) serve as the base
imaging set. Additional MR sequences
are co-registered as required, such as
tractography and fMRI. In order to minimize the risk of vascular injury, catheter
angiography is acquired, and a threedimensional cone-beam angiographic CT
is reconstructed using Siemens DynaCT
(Siemens, Munich, Germany) technology.
This imaging technique provides better
definition of small vessels in the late
arterial and early venous phases that
are poorly identified with traditional CT
angiography. Furthermore, CT imaging
of the calvarium improves the ability to
avoid cranial defects from prior surgery
and regions of skull too thin to effectively
anchor the electrode bolt.
The implant plan is individualized on the
basis of the AEC hypothesis, but typically
comprises 8-16 electrodes. In general,
trajectory planning for SEEG utilizes
typical rules for stereotaxy, including entry
points along gyral crowns, avoidance of
vessels, sulci and ventricle ependymal
surfaces. Full discussion of the nuances
of trajectory planning for interrogation
of all relevant supratentorial structures
with potential epileptogenic potential
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Figure 4
A 37 year-old female with a history of complex partial seizures secondary generalization had undergone prior temporal lobectomy for
presumed mesial temporal onset based on scalp EEG, with no change in seizure character or frequency post-operatively. She subsequently
underwent SEEG implantation (A), including a novel technique for insular lobe recordings along the triangular borders of the insular cortex
(arrows). Ictal recordings demonstrated broad insular onset, for which the patient underwent planned subtotal insular resection (B). Given
the oblique trajectory and entry outside of the planned craniotomy, the insular triangulation electrodes were left in place during surgery in
order to aid identification of the insular borders. Post-operative MR imaging demonstrated the insular resection (C).

is beyond the scope of this article, but
several features unique to SEEG planning
deserve mention. Stereo-EEG enables
recording of the entire cortical grey
matter from gyrus to sulcal depth, so it
may be advantageous in certain situations
for entry to be slightly off the gyral crown.
Ideally, trajectories should be planned
orthogonal to the skull surface in order
to avoid drill skiving, but highly oblique
trajectories may prove useful, especially
when interrogation of discrete surface
and deep structures can be achieved
with a single electrode. SEEG also
requires significantly more trajectories
per patient than typical applications for
frame-based stereotactic surgery (such
as DBS or needle biopsy). As such, planning requires careful attention in avoiding
electrode collision. Furthermore, thought
must be given to approximate location
of fixation pins on the stereotactic frame
during planning, so that they do not
interfere with planned trajectories after
frame placement. For this reason, we
use the CRW frame (Integra, Plainsboro,
NJ) during SEEG procedures because of
the increased freedom in pin placement
compared to other stereotactic frames.
Following initial completion, trajectories
are evaluated for safety and adequacy
of hypothesis testing within the AEC
framework in a meeting of all members
of the Epilepsy and Neuromodulation
Neurosurgery team.

On the day of surgery, the CRW stereotactic frame is applied under local
anesthesia to facilitate ideal pin positioning in an awake, cooperative patient.
High-resolution three-dimensional noncontrast CT imaging is acquired with the
localizer frame to define stereotactic
space, and pre-operative images (with
planned trajectories) are co-registered to
the sterotactic scan. Anesthesia is induced
after awake fiber-optic intubation. During
this time, the NeuroMate stereotactic
robotic platform (Renishaw, Gloucester,
UK) is set up and calibration tests are
performed to ensure accuracy of the
system prior to initiation of the procedure.
Once the anesthetized patient is fixed to
the robot frame attachment, accuracy
is again confirmed using test trajectories (with 2mm error being considered
maximum tolerance, though in practice
submillimeter accuracy is maintained).
The robot is used in place of a manual
stereotactic arc to orient instruments
along the planned trajectory. Anchor
bolts are placed percutaneously, using
a 2.0mm non-skiving drill bit (SurgiBit,
Sydney, Australia) to slightly under-drill
the hole for electrode anchor bolts
with 2.1mm outer diameter (PMT Corp,
Chanhassen, MN), which is placed after
cautery of the dura/pia with an insulated
ablation probe (PMT Corp, Chanhassen,
MN). Following placement of all anchor
bolts, the O-Arm intra-operative CT

scanner (Medtronic Inc., Minneapolis,
MN) is draped and brought into the field.
The O-Arm is used to obtain plain x-ray
images of a guiding stylette placed to the
planned target, and final position of the
electrode (PMT Corp, Chanhassen, MN),
is then confirmed relative to images with
the stylette. Active recording length of the
electrode is determined by the number
of contacts (available in even increments from 8 to 16 contacts), based on
pre-operatively planned targets. After all
electrodes are placed, the O-Arm is used
to obtain a three-dimensional CT scan,
which is co-registered to pre-operative
imaging to confirm accuracy of electrode
placement.
As worldwide experience with SEEG has
increased, the relative advantages and
disadvantages of the technique have
emerged. Concerns with regard to the
safety of SEEG implantation, particularly
within the North American literature,10
have been addressed. A recent metaanalysis of the reported intracranial
monitoring literature by Mullin et al.
showed that SEEG has a better safety
profile compared to subdural grid or
strip recording, with an overall complication rate of 1.3% compared to 4.0%
with subdural recordings. 11 Subdural
electrodes were shown to have statistically significant increased risk of both
hemorrhagic and infectious complications. That said, both techniques have
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hemorrhage in the anterior temporal
white matter. All patients with surgically
resectable focal epilepsy have undergone
subsequent resective or ablative surgery.
Five patients in this series have undergone
RNS as a result of SEEG implantation, due
to identification of bitemporal or eloquent
cortex EZ.

LASER INTERSTITIAL
THERMOTHERAPY

Figure 2
Ictal onset in a 46 year-old male with complex partial seizures was unable to be
localized or lateralized on the basis of scalp EEG monitoring. He subsequently
underwent SEEG implantation, including bitemporal electrode implantation, and
was found to have seizures originating independently in the mesial temporal lobes
bilaterally. Both hippocampi were cannulated along their long axes and 4 contact
depth electrodes were connected to the NeuroPace device, which is anchored in the
skull following a craniectomy.

demonstrated similar very low rates of
mortality and permanent morbidity (0.50.6%). While SEEG has shown benefit in
recording deep structures, many authors
have suggested that grid implantation
continues to show benefit in mapping of
functional cortex (particularly wernicke’s
area), though techniques to facilitate
brain mapping with SEEG continue to be
developed.12,13
In our experience to date at Jefferson, 27
patients have undergone implantation of
a total of 342 electodes (mean 12.7, range
5-17). No patient experienced permanent
morbidity or mortality related to the SEEG
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procedure. Two patients experienced
transient neurological deficits following
electrode implantation into eloquent
cortex. One patient experienced transient
quadrantanopsia following calcarine
cortex implantation, resolving over two
days. Another patient with baseline
severe receptive aphasia experienced
transient worsening of his aphasia after
electrode placement into Wernicke’s area,
resolving over several days. No patients
experienced clinically relevant intracranial hemorrhage, though 2 patients were
found to have trace convexity subdural
hematoma and a 5mm intraparenchymal

Laser ablation has arisen in response
to two older minimally invasive ablative
techniques: radiofrequency (RF) thermocoagulation and stereotactic radiosurgery
(SRS). Thermal ablation for focal epilepsy
was initially described using radiofrequency (RF) thermocoagulation probes.
However, while the thermocouple feature
of RF probes allows for thermal monitoring at the electrode tip, this technique
does not allow for monitoring of the
ablation zone as it expands, particularly
in relation to the volume of interest and
adjacent eloquent structures. Radiosurgical treatment of epileptogenic foci
has shown efficacy, but must contend
with radiobiologic complications such
as radionecrosis, as well as the inherently delayed effect of treatment. As
such, LITT has emerged as a therapeutic
modality by which heat deposition into
tissue can be monitored in real time in
the MRI environment. Laser energy is
absorbed in a variable manner depending
on wavelength, tissue characteristics, and
proximity to diffusive heat sinks such as
CSF spaces and blood vessels. Alterations
in proton resonant frequency can be
used to extract temperature dependent
component of tissue chemical shift in
gradient recalled echo (GRE) sequences,
resulting in real-time measurement of
tissue temperatures within 1°C.14 As a
result, MRI can be used to identify the
precise location of a stereotactically
placed laser probe, and monitor tissue
heating during laser energy deposition.
Lesion growth is estimated as heating
continues, with temperatures above 60°C
resulting in instantaneous cell death and
time/temperature dependent cell death
for temperatures between 45-60°C.
Since the introduction of LITT, the technique has been increasingly used for both
oncology and epilepsy neurosurgical
indications.15,16
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Figure 4
A 7-year old patient with gelastic seizures and precocious puberty was found to have a large hypothalamic hamartoma A. T2-weighted
image). Given the significant morbidity associated with open surgical resection or detachment of these lesions, the patient was recommended for LITT. Intra-procedural MRI shows the accuracy of the stereotactic laser probe placement of the laser probe B. T-1-weighted
image without contrast). Real-time thermography guided ablation of the lesion, while preventing unintended heat deposition into the
nearby hypothalamus. Post-contrast imaging confirmed the ablation of the hamartoma, including its attachment on the left hypothalamus.

Surgical planning for laser ablation
varies with target, but in the Jefferson
experience, targeting the amygdalohippocampal complex for mesial temporal
sclerosis (MTS) is the most common
indication. Long-axis cannulation of
the mesial structures is planned from
a posterior entry point, which typically
is found within a 1cm radius of a point
5cm superior and lateral to the inion.
The standard trajectory takes an extraventricular course in the white matter
lying between the collateral sulcus and
the floor of the lateral ventricle. Cerebrospinal fluid within the basal cisterns
and the ventricle also acts as a heat sink
to constrain thermal injury within the
mesial structures. A relative trade-off
exists between the volume of amygdala
ablated and the posterior extent of the
hippocampal body/fornix ablation, which
is adjusted individually based on anatomic
and semiological findings. An anatomic
study by Wu et al. elucidates several of the
nuances of LITT trajectory planning for
MTLE in further detail.17 Intra-operatively,
a manual arc-ring system is used with
the CRW frame to guide placement of
the anchor bolt, instead of the robotic
system, given the time involved setting
up the robot is not justified for a single
trajectory. After drilling placement of
a bone anchor bolt, a laser probe is
advanced to target. In MTS cases, we

have found that advancing a rigid stylette
to target prior to placement of the laser
probe results in less deviation by creating
a tract in the firm, gliotic hippocampus.
The patient is then transported to MRI
(though intra-operative MRI is very well
suited to this technique, if available), and
the thermal ablation performed during
real time thermography, mapped onto
anatomic T1-weighted images.
In the epilepsy population, LITT has
proved most beneficial in patients with
MTS, hypothalamic hamartoma (HH), and
deep nodular heterotopias. In one series
of 13 adult patients with mesial temporal
lobe epilepsy (MTLE) with or without
MTS, LITT resulted in approximately 60%
destruction of the amygdalohippocampal
volume and 54% seizure freedom at a
mean follow-up of 14 months.15 Our own
institutional experience has demonstrated
similar results, with 53% seizure freedom
at 6 months, 36.4% at 1 year, and 60% at
2-year follow-up (loss to follow-up in a
small patient sample resulting in the variable results within the study period). 18
Results in pediatric patients harboring
HH have shown significantly lower postoperative complications compared to
open surgical resection. In the Jefferson
practice, laser amygdalohippocampectomy is offered instead of open
selective amygdalohippocampectomy

(SAH) for patients with MTS and select
MTLE patients. While early experience
has shown a decreased rate of seizure
freedom compared to anterior temporal
lobectomy (ATL), the minimally invasive
technique, sparing of neocortical structures, and relatively high success rate have
made it an appealing option for these
patients. Patients are counseled that
salvage ATL is still possible in the event
of failed laser ablation, with complete
seizure freedom in 75% of patients
requiring salvage ATL in our experience.

RESPONSIVE
NEUROSTIMULATION
Responsive neurostimulation is a variation
on traditional neurostimulation paradigms such as spinal cord stimulation
(SCS), deep brain stimulation (DBS), and
vagal nerve stimulation (VNS). However,
unlike these other forms of neurostimulation, which deliver current continuously,
the NeuroPace device (NeuroPace,
Mountain View, CA) delivers current
only in response to a detected seizure,
effectively prolonging battery life and
minimizing side effects. In order to do so,
the device captures electrocorticography
(ECoG) from up to 8 channels via strip,
depth, or combined strip and depth electrode implants attached to the device.
The patient is taught to download ECoG
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recordings following a seizure so that
the treating Neurologist can “teach” the
device to recognize ictal onset and deliver
a current impulse in order to terminate the
seizure. This effectively uses the patient’s
unique seizure as an electrical biomarker
to govern neurostimulation treatment.
Following the results of the Pivotal trial,
the device received FDA approval in 2013
for treatment of partial epilepsy.
As mentioned above, the device accommodates two 4-contact implanted
electrodes, either strip, depth, or a
combination. This modular configuration allows the implant to be tailored to
a given patient. One common implant
strategy includes bi-hippocampal depth
electrodes for independent, bitemporal
epilepsy, with long-axis cannulation as
described above for laser ablation. For
patients with seizures arising from a solitary temporal lobe after contralateral ATL,
a hippocampal depth electrode is paired
with a posterior basal sub-temporal strip
electrode in an attempt to electrically
trap outflow from the temporal lobe.
In the case of seizures arising from the
paracentral lobule, a pair of subdural strips
over the medial and lateral sensorimotor
cortices is often employed. A craniotomy
is performed so that the implantable pulse
generator can be anchored to the skull
while sitting flush with the outer table.
The cranial incision is planned such that
only a small part of the incision requires
re-opening when the battery has to be
changed, and the electrode wires are
tunneled so as to avoid crossing this
segment of the incision, reducing risk of
damage during re-operation.
The results of the Pivotal Trial showed the
effect of RNS in a cohort of 191 patients
with drug-resistant epilepsy.19 During
the 12-week blinded treatment period,
patients were randomized to responsive
stimulation or seizure detection only.
During this phase of the study, stimulated
patients reported a decrease in seizure
frequency of 37% in the stimulation group
compared to 17% in the detection-only
group, however both groups reported
similar rates of >50% reduction (29% vs
27%). Interestingly, in the following openlabel phase of the trial, response rates
increased gradually over the course of two
years, with 44% and 53% seizure reduction
at 1- and 2- year follow-up, respectively.20
Surgical complications included surgical
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site infections in 3% of patients, 6% rate
of stimulation-induced paresthesias, and
approximately 5% of patients reporting
increase in both partial and generalized
seizures. Overall, the benefit lies with its
adaptability, but given the very low rate
of seizure freedom with RNS, it should
be considered alongside VNS and DBS
as a palliative neurostimulation option
for epilepsy. Continued development of
the NeuroPace device, particularly an
increase in the number of available channels, as well as increasing experience in
patient selection and implant configuration may well improve outcomes with
RNS over time.

CONCLUSION
Stereotactic surgical techniques make
up an increasingly important component
of the interventions for drug-resistant
epilepsy. In particular, the complexity of
trajectory planning greatly exceeds other
stereotactic applications given the need
to tailor depth electrode monitoring,
ablative therapy, or neurostimulation
therapy to the individual patient. Finally,
every intervention should be carefully
considered as part of coordinated,
multi-specialty care, which develops
anatomo-electrico-clinical hypotheses
that are tested and treated in a patientspecific manner.
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